Berend J van der Wilk

15PUBLICATIONS
34CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersEpidemiological modellingRadiation therapyLearning analytics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|May 25, 2026
Active surveillance for esophageal cancer after clinically complete response: relevant considerations of the SANO-trial.

|Jan 27, 2026
Health-related quality of life of patients undergoing active surveillance versus standard surgery for oesophageal cancer (SANO trial).

Sanjiv S G Gangaram Panday, Berend J van der Wilk, Ben M Eyck

|Feb 12, 2025
Detecting residual disease after neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma: The prospective multicentre preSINO trial.

Yang Yang, Zhichao Liu, Ian Wong

|Aug 14, 2024
Prolonged Time to Surgery in Patients With Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer.

Hidde C G Overtoom, Ben M Eyck, Berend J van der Wilk

|Aug 16, 2023
Characteristics Predicting Short-Term and Long-Term Health-Related Quality of Life in Patients with Esophageal Cancer After Neoadjuvant Chemoradiotherapy and Esophagectomy.

Berend J van der Wilk, Ben M Eyck, Bo J Noordman

|Jul 07, 2023
Active surveillance of oesophageal cancer after response to neoadjuvant chemoradiotherapy: dysphagia is uncommon.

Maria J Valkema, Manon C W Spaander, Jurjen J Boonstra

Pageof 3

Frequent Collaborators

7 joint publications

Ben M Eyck

4 joint publications

Mark I van Berge Henegouwen

4 joint publications

Bas P L Wijnhoven

3 joint publications

Bo J Noordman